Biologics Outsourcing Market Size, Share & Trends Analysis Forecast 2027

Industry Insights

The report covers the forecast and analysis of the Biologics Outsourcing market on a global and regional level. The study provides historical data from 2013 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the Biologics Outsourcing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Biologics Outsourcing market on a global level.

In order to give the users of this report a comprehensive view of the Biologics Outsourcing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Biologics Outsourcing market by segmenting the market based on product, type, source, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Cost & time-saving benefits provided by biologics outsourcing activities will further propel the market expansion over the period from 2019 to 2027. Moreover, the biotech & pharma firms can save huge capital expenditure through biologics outsourcing and increase the invention and commercialization of the biologics over the forecast period, thereby prompting the market growth over the forecast timespan. Nevertheless, the high technical need for manufacturing biologics will impede business expansion.

On the basis of the product, the market for biologics outsourcing is divided into Antibody, Vaccines, Recombinant Protein, and Others. Based on the type, the industry is classified into Instruments and Kits & Reagents. On the basis of source, the industry is classified into Mammalian, Microbial, and Others.  Applications-wise, the market is segregated into Vaccine & Therapeutics Development, Stem Cell Research, Blood & Blood-Related Products Testing, Tissue & Tissue Related Products Testing, and Cellular & Gene Therapy.

Report Scope

Some of the leading players in the global market include

• Sino Biological Inc.
•  Innovent Biologics Inc.
•  Syngene
•  GenScript
•  Boehringer Ingelheim GmbH
•  Abzena PLC
•  Adimab LLC
•  Albany Molecular Research Inc.
•  Catalent Inc.
•  GL Biochem Corporation Ltd.
•  JHL BIOTECH Inc.
•  GVK Biosciences Private Limited
•  Lonza
•  ProteoGenix
•  Selexis SA
•  Shanghai Medicilon Inc.
•  Horizon Discovery Group plc
•  The Jackson Laboratory

This report segments the Biologics Outsourcing market as follows:

By Product   Analysis

• Antibody
  • Monoclonal Antibody
  • Bi-specific Antibody
  • Antibody Drug Conjugates
• Vaccines
• Recombinant Protein
• Others

By Type Analysis

• Instruments
• Kits & Reagents

By Source Analysis

• Mammalian
• Microbial
• Others

By Applications Analysis

• Vaccine & Therapeutics Development
• Stem Cell Research
• Blood & Blood-Related Products Testing
• Tissue & Tissue Related Products Testing
• Cellular & Gene Therapy

By Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa